All In Biotech

Drug Trial Radar · NCT00532779

A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

A Multicenter, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Two Doses of Naltrexone Sustained Release (SR)/Bupropion Sustained Release (SR) and Placebo in Obese Subjects

Last checked: Nov 19, 2026Latest source record: Nov 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,742 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,742

Actual

Start

Oct 2007

Primary completion

May 2009

Study completion May 2009

Sponsor

Lead sponsor
Orexigen Therapeutics, IncIndustry
Sponsor type
Industry
First posted
Sep 20, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether 2 doses of the combination of naltrexone SR and bupropion SR are safe and effective in the treatment of obesity.

Conditions

  • Obesity
  • Overweight

Interventions

  • Naltrexone SR 16 mg/Bupropion SR 360 mg /dayDrug

  • Naltrexone SR 32 mg/Bupropion SR 360 mg /dayDrug

  • PlaceboDrug

  • Ancillary therapyBehavioral

    Ancillary therapy consisting of diet instruction, advice on behavior modification, and exercise counseling

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Co-primary: Body Weight- Mean Percent ChangeTime frame: Baseline, 56 weeks
  2. Co-primary: Body Weight- Proportion of Subjects With ≥5% DecreaseTime frame: Baseline, 56 weeks

Locations

34 sites in 1 country. Site status is shown where the registry gives one.

  • Radiant Research

    Birmingham, Alabama

  • SelfCenter, PC

    Fairhope, Alabama

  • Radiant Research, Phoenix Southeast

    Chandler, Arizona

  • Advanced Clinical Research Institute

    Anaheim, California

  • Advance Clinical Research Institute

    Orange, California

  • Scripps Clinic Del Mar

    San Diego, California

  • VA San Diego Healthcare System

    San Diego, California

  • Miami Research Associates

    Miami, Florida

  • University Clinical Research

    Pembroke Pines, Florida

  • Georgia Clinical Research

    Atlanta, Georgia

  • CSRA Partners in Health, Inc

    Augusta, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Radiant Research

    Chicago, Illinois

  • Welborn Clinic

    Evansville, Indiana

  • Radiant Research Kansas City

    Overland Park, Kansas

  • Central Kentucky Research Associates, Inc.

    Lexington, Kentucky

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana

  • Medical Research Institute

    Slidell, Louisiana

  • Health Trends Research, LLC

    Baltimore, Maryland

  • FutureCare Studies

    Springfield, Massachusetts

  • Center for Nutrition and Metabolic Disorders

    Reno, Nevada

  • Center for Nutrition and Preventive Medicine

    Charlotte, North Carolina

  • Wake Research Associates, LLC

    Raleigh, North Carolina

  • Rapid Medical Research, Inc.

    Cleveland, Ohio

  • Central Ohio Nutrition Center, Inc.

    Columbus, Ohio

  • Lynn Health Science Institute

    Oklahoma City, Oklahoma

  • Summit Research Network (Oregon), Inc.

    Portland, Oregon

  • Internal Medicine Associates of Cordova

    Cordova, Tennessee

  • Jackson Clinic, PA

    Jackson, Tennessee

  • Covance Clinical Research Unit Austin

    Austin, Texas

  • Radiant Research

    Dallas, Texas

  • Baylor Endocrine Center

    Dallas, Texas

  • Radiant Research

    San Antonio, Texas

  • Oakwell Clinical Research

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.